We invite volunteers to participate in the study of anti-tuberculosis vaccine

A set of healthy volunteers aged 18-45 years has been opened to participate in the study of a new anti-tuberculosis vaccine for adults. Details of participation can be discussed with the chief researcher Professor Maria Vershinina - 89932027840 (WhatsApp)

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen